keyword
https://read.qxmd.com/read/38603531/high-need-beneficiary-enrollment-patterns-in-medicare-advantage-and-traditional-medicare
#1
JOURNAL ARTICLE
Aig Unuigbe, Inna Cintina, Julia Sheriff, Lane Koenig
OBJECTIVES: High-need Medicare beneficiaries require elevated levels of care and coordination to manage their conditions. We evaluated the extent to which high-need beneficiaries enrolled in Medicare Advantage (MA) or traditional Medicare (TM) accountable care organizations (ACOs) relative to TM non-ACOs. STUDY DESIGN: Using Medicare claims and MA encounter data, we identified 3 groups of high-need beneficiaries: (1) individuals younger than 65 years with a disability or end-stage kidney disease, (2) frail individuals, and (3) older individuals with major complex or multiple noncomplex chronic conditions...
April 2024: American Journal of Managed Care
https://read.qxmd.com/read/37941718/association-of-admission-functional-status-and-body-mass-index-with-mortality-in-patients-receiving-chronic-dialysis-a-nationwide-observational-cohort-study
#2
JOURNAL ARTICLE
Shintaro Mandai, Takaaki Koide, Tamami Fujiki, Yutaro Mori, Fumiaki Ando, Koichiro Susa, Takayasu Mori, Soichiro Iimori, Shotaro Naito, Eisei Sohara, Shinichi Uchida, Kiyohide Fushimi, Tatemitsu Rai
INTRODUCTION: Chronic kidney disease (CKD) significantly affects activities of daily living (ADLs) before and after the initiation of dialysis, particularly in elderly individuals. However, the impact of admission functional status on dialysis patients' outcome is not fully understood. This study aimed to investigate the effect of the number of ADL disabilities usually measured for all patients hospitalized in Japan on in-hospital outcome for dialysis patients. METHODS: Using an inpatient administrative claims database, we included 104,557 admissions of patients undergoing chronic dialysis aged 65 years and above from 2012 to 2014...
October 16, 2023: JMA journal
https://read.qxmd.com/read/37812967/health-status-and-comorbidities-of-adult-patients-with-late-diagnosed-phenylketonuria-pku-born-before-the-newborn-screening-in-france-a-nationwide-study-of-health-insurance-claims-data
#3
JOURNAL ARTICLE
Claire Douillard, Jean-Baptiste Arnoux, Stéphane Bouée, Christian Jacob, Kim Maren Schneider, Julia Theil, Sybil Charrière, Francois Maillot
BACKGROUND: Phenylketonuria (PKU) is an inborn error of metabolism. When diagnosed late, it causes developmental delay or severe irreversible intellectual disability. This study aimed at evaluating the health status and healthcare consumption of late-diagnosed PKU patients in France. METHODS: This retrospective observational study used health insurance claims data from the French SNDS (Système National des Données de Santé) database, which contains data from over 66 million French inhabitants...
September 29, 2023: Molecular Genetics and Metabolism
https://read.qxmd.com/read/37297727/effect-of-the-frequency-of-rehabilitation-treatments-on-the-long-term-mortality-of-stroke-survivors-with-mild-to-moderate-disabilities-under-the-korean-national-health-insurance-service-system
#4
JOURNAL ARTICLE
Dougho Park, Kang Ju Son, Jong Hun Kim, Hyoung Seop Kim
Given the increase in stroke-related social costs, studies on survival and functional prognosis after stroke are urgently needed. Therefore, we investigated the relationship between the frequency of rehabilitation treatments in the acute and subacute phases of stroke and the long-term mortality of stroke survivors with mild-to-moderate disabilities. We performed a retrospective cohort study using data from the Korean National Health Insurance Service database. Our final cohort included 733 patients with national disability registration grades 4-6...
May 29, 2023: Healthcare (Basel, Switzerland)
https://read.qxmd.com/read/36972248/social-determinants-of-patiromer-adherence-and-abandonment-an-observational-retrospective-real-world-claims-analysis
#5
JOURNAL ARTICLE
Nathan Kleinman, Jennifer Kammerer, Kevin LaGuerre, Charuhas V Thakar
BACKGROUND: Hyperkalemia is a frequent and serious complication in chronic kidney disease (CKD) that can impede continuation of beneficial evidence-based therapies. Recently, novel therapies such as patiromer have been developed to treat chronic hyperkalemia, but their optimal utility hinges on adherence. Social determinants of health (SDOH) are critically important and can impact both medical conditions and treatment prescription adherence. This analysis examines SDOH and their influence on adherence to patiromer or abandonment of prescriptions for hyperkalemia treatment...
2023: PloS One
https://read.qxmd.com/read/36676673/chronic-kidney-disease-urinary-tract-infections-and-antibiotic-nephrotoxicity-are-there-any-relationships
#6
REVIEW
Ioana Dicu-Andreescu, Mircea Niculae Penescu, Cristina Căpușă, Constantin Verzan
Chronic kidney disease (CKD) has been a constant burden worldwide, with a prevalence of more than 10% of the population and with mortality reaching 1.2 million deaths and 35.8 million disability-adjusted life years (DALYs) in 2017, as it is claimed by the Global Burden of Diseases. Moreover, an increase in its prevalence is expected in the next years due to a rise in the number of people suffering from obesity, diabetes mellitus and hypertension. On the other hand, with cardiovascular morbidity and mortality showing a downward trend, maybe it is time to focus on CKD, to minimize the preventable risk factors involved in its progression toward end-stage kidney disease (ESKD) and to offer a better quality of life...
December 27, 2022: Medicina
https://read.qxmd.com/read/35928595/5-year-risk-of-adult-onset-chronic-diseases-during-childhood-and-adolescent-transitioning-for-individuals-with-cerebral-palsy
#7
JOURNAL ARTICLE
Daniel G Whitney
Epidemiologic evidence documenting risk of chronic diseases as children with cerebral palsy age throughout growth is lacking to inform prevention strategies. The objective was to characterize the 5-year risk of chronic diseases that are typically associated with advanced aging among < 1-13 year olds with cerebral palsy and effects by patient-level factors. This retrospective cohort study used nationwide commercial administrative claims from 01/01/2001-12/31/2018 from children < 1-13 years old with ≥ 5 years of mostly continuous insurance enrollment...
October 2022: Preventive Medicine Reports
https://read.qxmd.com/read/34906627/patient-frailty-and-functional-use-of-hemodialysis-vascular-access-a-retrospective-study-of-the-us-renal-data-system
#8
JOURNAL ARTICLE
Karen Woo, Laura Gascue, Keith Norris, Eugene Lin
RATIONALE & OBJECTIVE: Despite the high prevalence of frailty among dialysis patients, it is unknown whether frailty is associated with dialysis vascular access failure. This study examined the association between frailty and functional use of vascular access. STUDY DESIGN: Retrospective observational study. SETTING & PARTICIPANTS: Patients who initiated hemodialysis through a tunneled catheter in the US Renal Data System database from 2012 through 2017 and underwent subsequent creation of an arteriovenous fistula or graft...
July 2022: American Journal of Kidney Diseases
https://read.qxmd.com/read/33901377/-the-technology-of-enhancement-of-detection-of-chronic-renal-diseases
#9
JOURNAL ARTICLE
O N Kotenko, S M Serdyukovskiy, N K Grishina, A I Ibragimov
The chronic kidney disease takes a special place among chronic non-communicable diseases because it is characterized by wide prevalence worldwide. However, its detection rate among Moscow adult population is 1%, though in the European countries this indicator is significantly higher and is made up on average to 6%. At the terminal stage of chronic kidney disease, quality of life of such patients decreases dramatically, that result in working capacity loss and disability. These patients often require expensive methods of programmed hemo- and peritoneal dialysis...
March 2021: Problemy Sot︠s︡ialʹnoĭ Gigieny, Zdravookhranenii︠a︡ i Istorii Medit︠s︡iny
https://read.qxmd.com/read/31810527/early-onset-noncommunicable-disease-and-multimorbidity-among-adults-with-pediatric-onset-disabilities
#10
JOURNAL ARTICLE
Daniel G Whitney, Rachael T Whitney, Neil S Kamdar, Edward A Hurvitz, Mark D Peterson
OBJECTIVE: To determine the prevalence of major noncommunicable diseases among young adults with pediatric-onset disabilities (PoDs) compared with young adults without PoDs. PATIENTS AND METHODS: Data were obtained from the Optum Clinformatics Data Mart, a de-identified nationwide claims database of beneficiaries from a single private payer in the United States. Beneficiaries were included if they were 18 to 40 years old and had an International Classification of Diseases, Ninth Revision, Clinical Modification diagnostic code for a PoD known to originate in childhood...
February 2020: Mayo Clinic Proceedings
https://read.qxmd.com/read/31286072/chronic-conditions-medically-supportive-care-partners-and-functional-disability-among-cognitively-impaired-adults
#11
JOURNAL ARTICLE
Peter H Van Ness, Janet MacNeil Vroomen, Linda Leo-Summers, Brent Vander Wyk, Heather G Allore
BACKGROUND AND OBJECTIVES: To assess whether medically supportive care partners modify the associations of symptomatic chronic conditions with the number of functional disabilities in a cohort of multimorbid older adults with cognitive impairment. RESEARCH DESIGN AND METHODS: The research design is a prospective study of a nationally representative cohort of Medicare beneficiaries. National Health and Aging Trends Study (NHATS) data were linked with Medicare claims for years 2011-2015...
May 2019: Innovation in Aging
https://read.qxmd.com/read/27518165/patient-function-long-term-survival-and-use-of-surgery-in-patients-with-kidney-cancer
#12
JOURNAL ARTICLE
Hung-Jui Tan, Karim Chamie, Timothy J Daskivich, Mark S Litwin, Jim C Hu
BACKGROUND: Beyond age and comorbidity, functionality can shape the long-term survival potential of patients with cancer. Accordingly, herein the authors compared mortality and receipt of cancer-directed surgery according to patient function among older adults with kidney cancer. METHODS: Using Surveillance, Epidemiology, and End Results (SEER)-Medicare data from 2000 through 2009, the authors studied 28,326 elderly subjects with primary kidney cancer. Patient function was quantified using function-related indicators, claims indicative of dysfunction and disability...
December 15, 2016: Cancer
https://read.qxmd.com/read/23531963/brief-update-on-the-burden-of-diabetes-in-south-carolina
#13
REVIEW
Khosrow Heidari, Patsy M Myers, Kathie Hermayer
Diabetes is a serious disease, which is often accompanied by complications, such as blindness, kidney failure, heart attacks, strokes and amputations. High blood pressure and abnormal cholesterol levels are frequent comorbidities. Diabetes has an immense impact on public health and medical care. In South Carolina (SC), medical costs rise with increased duration of the disease, and lifespan is shortened by 5 to 10 years in most patients. To describe the burden of diabetes in SC, we examined the public health surveillance systems available to estimate the prevalence, mortality and hospitalization rates and some disability statistics and hospital charges...
April 2013: American Journal of the Medical Sciences
https://read.qxmd.com/read/22382455/disability-and-decline-in-physical-function-associated-with-hospital-use-at-end-of-life
#14
JOURNAL ARTICLE
Amy S Kelley, Susan L Ettner, R Sean Morrison, Qingling Du, Catherine A Sarkisian
BACKGROUND: Hospital use near the end of life is often undesirable to patients, represents considerable Medicare cost, and varies widely across regions. OBJECTIVE: To concurrently examine regional and patient factors, including disability and functional decline, associated with end-of-life hospital use. DESIGN/PARTICIPANTS: We sampled decedents aged 65 and older (n = 2,493) from the Health and Retirement Study (2000-2006), and linked data from individual Medicare claims and the Dartmouth Atlas of Health Care...
July 2012: Journal of General Internal Medicine
https://read.qxmd.com/read/21617570/effect-of-patient-selection-method-on-provider-group-performance-estimates
#15
COMPARATIVE STUDY
Carolyn T Thorpe, Grace E Flood, Sally A Kraft, Christine M Everett, Maureen A Smith
BACKGROUND: Performance measurement at the provider group level is increasingly advocated, but different methods for selecting patients when calculating provider group performance have received little evaluation. OBJECTIVE: We compared 2 currently used methods according to characteristics of the patients selected and impact on performance estimates. RESEARCH DESIGN, SUBJECTS, AND MEASURES: We analyzed Medicare claims data for fee-for-service beneficiaries with diabetes ever seen at an academic multispeciality physician group in 2003 to 2004...
August 2011: Medical Care
https://read.qxmd.com/read/18279115/the-economic-impact-of-pre-dialysis-epoetin-alpha-on-health-care-and-work-loss-costs-in-chronic-kidney-disease-an-employer-s-perspective
#16
COMPARATIVE STUDY
Erick Moyneur, Brahim K Bookhart, Samir H Mody, Andrée-Anne Fournier, David Mallett, Mei Sheng Duh
The objective of the study was to quantify the direct and indirect incremental costs of epoetin alpha (EPO) therapy for anemia in pre-dialysis chronic kidney disease (CKD). Using employer claims data from January 1998 to January 2005, direct (medical and pharmacy) and indirect (sick leave and disability) costs were compared between CKD-anemic patients treated with EPO before dialysis (n = 199) and those not treated with an erythropoiesis-stimulating therapy (EST) (n = 196). Among the results, incremental direct and indirect cost savings for EPO-treated patients were $1443 and $328 per member per month (PMPM) (p < 0...
February 2008: Disease Management: DM
https://read.qxmd.com/read/16776884/employer-paid-nonmedical-costs-for-patients-with-diabetes-and-end-stage-renal-disease
#17
JOURNAL ARTICLE
Sachin J Kamal-Bahl, Susan Pantely, Bruce Pyenson, Charles M Alexander
INTRODUCTION: Disease conditions such as end-stage renal disease (ESRD), which have severe consequences of disability and mortality, can generate substantial costs for large employers providing life insurance and disability insurance benefits. This study is the first to examine such disease-related nonmedical costs for employers and models the following employer-paid costs for ESRD in patients with diabetes: 1) life insurance benefits, 2) disability benefits, and 3) cost of replacing a worker...
July 2006: Preventing Chronic Disease
https://read.qxmd.com/read/16283863/economic-burden-of-patients-with-anemia-in-selected-diseases
#18
JOURNAL ARTICLE
William B Ershler, Kristina Chen, Eileen B Reyes, Robert Dubois
OBJECTIVE: To examine the economic impact of patients with anemia in selected diseases. METHODS: A retrospective cohort design was used to estimate the differences in costs between anemic and nonanemic patients. The analysis used administrative claims data (1999-2001) from a US population to assess direct costs and disability and productivity data (1997-2001) to estimate indirect costs. Adult patients with a diagnosis of rheumatoid arthritis (RA), inflammatory bowel disease (IBD), chronic obstructive pulmonary disease (COPD), chronic kidney disease (CKD), cancer, or congestive heart failure (CHF) were identified...
November 2005: Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research
https://read.qxmd.com/read/8510638/surveillance-for-diabetes-mellitus-united-states-1980-1989
#19
JOURNAL ARTICLE
L S Geiss, W H Herman, M G Goldschmid, F DeStefano, M S Eberhardt, E S Ford, R R German, J M Newman, D R Olson, S J Sepe
PROBLEM/CONDITION: In the United States, diabetes mellitus is the most important cause of lower-extremity amputation and end-stage renal disease; the major cause of blindness among working-age adults; a major cause of disability, premature mortality, congenital malformations, perinatal mortality, and health-care costs; and an important risk factor for the development of many other acute and chronic conditions (e.g., diabetic ketoacidosis, ischemic heart disease, stroke). Surveillance data describing diabetes and its complications are critical to increasing recognition of the public health burden of diabetes, formulating health-care policy, identifying high-risk groups, developing strategies to reduce the burden of this disease, and evaluating progress in disease prevention and control...
June 4, 1993: MMWR. CDC Surveillance Summaries: Morbidity and Mortality Weekly Report. CDC Surveillance Summaries
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.